Qa & Gmp 29 May2010
Recruitech International
SPCs as Targets for Litigation: C5 Presentation 18 February 2009
WuXi Pharma Fourth Quarter 2012 Earnings Presentation
Volunteer recruitment in clinical trials
HOW DO WE GET THE ANTIBIOTICS WE NEED? Opportunities and challenges posed and lessons learned from recent submissions Dr. Flic Gabbay Senior Partner TranScrip.
1 Technology Transfer: the NIH Experience Mark Rohrbaugh, Ph.D., J.D. Director Richard Rodriguez, M.B.A. Director, Division of Technology Development &
John G. Bartlett, MD Program Chair Professor of Medicine Johns Hopkins University School of Medicine Baltimore, MD.
Prof. Rosanna Abbate Univ.di Firenze. Commonly-used anticoagulant treatments affect several steps of coagulation pathway Clot Intrinsic pathwayExtrinsic.
TB VACCINES: Whats New?? Dr S G KASI Consultant Pediatrician Bengaluru.
Species-Dependent Pharmacokinetics of CMX001, An Orally-Available Prodrug of Cidofovir Being Developed for Treatment of Poxvirus Infection BM Lampert,
Clinical Trials on Trial The Patient Perspective Wim Vandevelde European AIDS Treatment Group (EATG) HAI Europe Open Seminar - November 21st 2008 - Berlin.
